IHH Annual Report 2024

IHH Annual Report 2024 1
Content 3
Group Overview 4
A Purpose-Led Approach 4
Navigating This Report 6
Investment Case 7
Clinical Excellence 8
IHH at a Glance 12
Financial Highlights 14
Operational Highlights 16
Our Sustainability Approach 18
Corporate Milestones 2024 20
Awards and Accreditations 22
Strategic Report 24
Chairman’s Statement 26
Group CEO’s Message 30
Business Strategy 34
Business Model 36
Impact of Value Creation 38
Operations Review 40
Malaysia 40
Singapore 41
Türkiye and Europe 42
India 43
Greater China 44
Parkway Life REIT 45
Laboratories 45
Financial Review 46
Market Outlook 48
Our Material Matters 52
Risk Management 53
Principal Risks 54
Governance 58
Board of Directors 59
Group Management 67
Country Leadership 71
Corporate Governance at a Glance 73
Corporate Governance Overview Statement 74
Nomination and Remuneration Committee Report 91
Audit Committee Report 96
Risk Management Committee Report 99
Statement on Risk Management and Internal Control 101
Investor Relations Report 109
Other Information 112
Additional Compliance Information 112
Directors’ Responsibility Statement 114
Financial Statements 115
Directors’ Report 116
Statement by Directors 122
Statutory Declaration 123
Independent Auditors’ Report 124
Statements of Financial Position 127
Statements of Profit or Loss and Other Comprehensive Income 129
Statements of Changes in Equity 130
Statements of Cash Flows 136
Notes to the Financial Statements 138
Additional Corporate Information 239
Analysis of Shareholdings 239
List of Top 30 Largest Shareholders 241
List of Top 10 Properties 243
Notice of Annual General Meeting 245
Form of Proxy 253

RkJQdWJsaXNoZXIy NDgzMzc=